Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Oropharyngeal Neoplasms 4Head and Neck Neoplasms 3Lung Neoplasms 2Glioblastoma 2Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Thymoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Smoking 1Sinonasal Squamous Cell Carcinoma 1Rectal Neoplasms 1Rectal Malignant Neoplasms 1Radiation Injuries 1Postoperative Complications 1Pathologic Complete Response 1Papillomavirus Infections 1Pancreatic Neoplasms 1Mouth Neoplasms 1Low Anterior Resection Syndrome 1Laryngeal Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1HPV-Related Squamous Cell Carcinoma 1Fatigue 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Radiotherapy 3fludarabine 2Cyclophosphamide 2pembrolizumab 1olaparib 1envafolimab 1avelumab 1Sunitinib 1Radiotherapy, Adjuvant 1Nivolumab 1Etoposide 1Drug Therapy 1Cisplatin 1Chemoradiotherapy 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × Chemoradiotherapy × 90 days × Clear all
NCT07479628 2026-03-18

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

Shanghai Chest Hospital

Phase 2 Not yet recruiting
31 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡